Small molecule NS5B RdRp non-nucleoside inhibitors for the treatment of HCV infection: A medicinal chemistry perspective

Z Zhou, J Zhang, E Zhou, C Ren, J Wang… - European Journal of …, 2022 - Elsevier
Hepatitis C virus (HCV) infection has become a global health problem with enormous risks.
Nonstructural protein 5B (NS5B) RNA-dependent RNA polymerase (RdRp) is a component …

[PDF][PDF] Immunogenicity prediction by VaxiJen: a ten year overview

N Zaharieva, I Dimitrov, D Flower… - J. Proteom …, 2017 - ddg-pharmfac.net
Vaccination stands alone as an unparalleled medical intervention able to save human lives
numbering hundreds of millions. Modern licensed vaccines are either whole organism …

Deguelin inhibits HCV replication through suppressing cellular autophagy via down regulation of Beclin1 expression in human hepatoma cells

W Liao, X Liu, Q Yang, H Liu, B Liang, J Jiang… - Antiviral Research, 2020 - Elsevier
Aims Deguelin, a natural compound derived from Mundulea sericea (Leguminosae) and
some other plants exhibits an activity to inhibit autophagy, a cellular machinery required for …

An overview of immune evasion strategies of DNA and RNA viruses

SS Naz, A Aslam, T Malik - Infectious Disorders-Drug Targets …, 2021 - ingentaconnect.com
A successful viral infection is due to the effective evasion of viruses of the immune system.
The entry of viruses is usually detected by different cellular receptors including PRRs …

Naturally occurring antiviral drug resistance in HIV patients who are mono‐infected or co‐infected with HBV or HCV in China

H Deng, X Deng, Y Liu, Y Xu, Y Lan… - Journal of Medical …, 2018 - Wiley Online Library
Drug resistance mutations (DRMs) may reduce the efficacy of antiviral therapy. However, the
studies focused on naturally occurring, pre‐existing DRMs among co‐infected patients in …

Factors influencing the prevalence of resistance-associated substitutions in NS5A protein in treatment-naive patients with chronic hepatitis C

KK Kyuregyan, VS Kichatova, AA Karlsen, OV Isaeva… - Biomedicines, 2020 - mdpi.com
Direct-acting antivirals (DAAs) revolutionized treatment of hepatitis C virus (HCV) infection.
Resistance-associated substitutions (RASs) present at the baseline impair response to DAA …

Physics Comes to the Aid of Medicine—Clinically-Relevant Microorganisms through the Eyes of Atomic Force Microscope

M Cieśluk, P Deptuła, E Piktel, K Fiedoruk, Ł Suprewicz… - Pathogens, 2020 - mdpi.com
Despite the hope that was raised with the implementation of antibiotics to the treatment of
infections in medical practice, the initial enthusiasm has substantially faded due to …

阿舒瑞韦联合达拉他韦治疗慢性丙型肝炎患者初步疗效及其病毒准种变化和耐药变异特征分析

卓丽, 许敏, 邓浩辉 - 实用肝脏病杂志, 2020 - manu43.magtech.com.cn
目的观察应用阿舒瑞韦(ASV) 联合达拉他韦(DCV) 治疗慢性丙型肝炎(CHC)
或代偿期丙型肝炎肝硬化患者的初步疗效, 并分析复发患者丙型肝炎病毒(HCV) …

Dynamic changes of HCV genomes under selective pressure from DAAs therapy in relapsed patients

H Deng, F Guo, W Yu, L Li, Y Xia, Y Guan, J Li - Virus Research, 2021 - Elsevier
Currently, direct-acting antiviral drugs (DAAs) are widely used as therapeutic methods for
hepatitis C virus (HCV)-positive patients, however, patients may experience treatment …

Major mutations in the NS3 gene region of hepatitis C virus related to the resistance to direct acting antiviral drugs: a systematic review

AEFM Mundim, FOF de Castro, MBB Albuquerque… - VirusDisease, 2020 - Springer
Hepatitis C virus (HCV) remains a global public health problem with high prevalence rates
and chronicity of infection. Present work aimed to describe the main mutations in the NS3 …